Where is the clean ammonia market headed?

Where is the clean ammonia market headed?

Up next

How has the prolonged downturn affected the chemical industry's ratings?

Daniel Krauss, director at S&P Global Ratings, joins the podcast for a discussion about the latest S&P Global Ratings chemicals report and the road ahead for the chemical industry. Topics include how the prolonged chemical downturn has affected credit ratings, the disparity in th ...  Show more

What does supply chain resilience look like in practice?

Sid Kalpattu Shivakumar, director of global market insights and Nouryon, joins the podcast for a deep dive into supply chain resiliency. Key themes include the multidimentional nature of supply volatility, how companies can manage multiple suppliers, and the role of AI and data i ...  Show more

Recommended Episodes

Net Zero Transitions: Blue carbon
Argus Media

Adam Nye, VP of Business Development for Argus Global Carbon Markets, talks to Nadeem Khan, CEO and Founder of Indus Delta Capital, and Chris Villiers, Director of Portfolio Management at Respira, about blue carbon, including:  

<ul><li>Key fundamentals and co-benefits of ...  Show more

Martin Werner of DD3 Capital on the Codere / DDMX SPAC deal
Yet Another Value Podcast

Martin Werner, co-founding partner of DD3 Capital, discusses DDMX's deal to deSPAC with Codere Online. Key topics include what DDMX was looking for in a deal, how DDMX worked with their partners in structuring their deal, and why DDMX thinks Codere Online's omnichannel ...  Show more

Feeling Good about Feeling Good
The Dividend Cafe

Today's Post - https://bahnsen.co/4fktJ0n

Exploring Market Optimism Amid Economic Trends and Forecasts

In this edition of Dividend Cafe, host David Bahnsen discusses the current optimism in small and large businesses as ca ...

  Show more

Checking In On The Housing Market… And The Future of Pharma & Health Care 2/18/25
CNBC's "Fast Money"

A check in on the housing market, as builder sentiment drops to a 5-month low. The concerns they have over looming tariffs, and the latest results out of one of the top players in the space. Plus Pharma in focus, as the country’s health agencies deal with funding cuts and pers ...

  Show more